Harnessing Liquid Biopsies to Transform Cancer Treatment Selection, Monitoring & Early Detection & Empower Precision Treatments

Time: 8:30 am
day: Day One


  • Reviewing current and future liquid biopsy assay use in cancer care, including early detection and molecular residual disease
  • Discussing recent collaborative frameworks and standards for best practices in liquid biopsy assay validation
  • Enabling broad access to liquid biopsy assays and global harmonization of regulatory requirements
  • Looking at what’s on the horizon: emerging trends in liquid biopsy assay development